IFNG and cancer: Although IFNγ signaling in cancer cells may orchestrate feedback inhibition mechanisms that limit antitumor immunity in certain contexts64, our results emphasize the critical role of IFNγ signaling in cancer cells for the effectiveness of DCP therapy.